Rani Therapeutics Hldgsの空売り状況は、投資家がRani Therapeutics Hldgsの株価下落に賭けている度合いを知ることができます。空売りデータは2週間ごとに更新されます。

Rani Therapeutics Hldgs (NASDAQ:RANI) 株価情報, 空売り情報

RANI THERAPEUTICS HOLDINGS-A

Rani Therapeutics Hldgs

Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads in liquid form with high bioavailability.

Rani Therapeutics Holdings, Inc. - Class A Common Stock

Rani Therapeutics Holdings Inc

Airbnb Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABNB#NASDAQ">ABNB</a>) issued its 2025 Summer Release, where it made several announcements.
Here are some key analyst takeaways.
<h1 class="wp-block-heading">Goldman Sachs On Airbnb</h1>
<a href="https://www.benzinga.com/analyst-stock-ratings/analyst/587e33195064ed000173030b/eric-sheridan">Analyst Eric Sheridan</a> reiterated a Neutral rating and price target of $139.
The analyst mentioned three main announcements by the company:
<ul class="wp-block-list">
<li>Introduction of Airbnb Services: These include 10 services, such as chefs, prepared meals and photography, that guests can book during their stay.</li>
<li>Introduction of Airbnb Experiences: "After rolling back their prior Experiences offering, the company reimagined Experiences from the ground up and will launch the offering across five main categories (e.g. History &amp; Culture, Food &amp; Drink, etc.) in 650 cities worldwide," Sheridan wrote.</li>
<li>App Redesign: Design and functionality improvements were announced for both the guest and the host to increase intuitiveness.</li>
</ul>
While these initiatives align with the company's "long-stated goal of executing against a multi-faceted growth opportunity," there is low visibility into how long these investments will be needed to scale the initiatives and when they will <a>contribute towards incremental growth</a>, he further stated.
Check out <a href="https://www.benzinga.com/analyst-stock-ratings">other analyst stock ratings</a>.
<h1 class="wp-block-heading">Needham On Airbnb</h1>
<a href="https://www.benzinga.com/analyst-stock-ratings/analyst/587635595064ed000140010c/scott-berg">Analyst </a><a href="https://www.benzinga.com/analyst-stock-ratings/analyst/587635595064ed000140010c/scott-berg">Bernie McTernan</a> reaffirmed a Hold rating on the stock.
Airbnb's announcements were broadly as expected, McTernan said. The relaunch of Experiences makes sense, as it helps aggregate supply that are disparate, he added.
"The difficulty is sizing the benefit as there is a wide range of potential outcomes, we think the bull bear variance will be large," the analyst wrote. For Airbnb to grow bookings buy more than 12.5% in 2026, Experiences and Services would have to drive bookings of $2.5 billion, he further stated.
ABNB Price Action: Shares of Airbnb had risen by 0.74% to $139.07 at the time of publication on Wednesday.
Read More: <a href="https://www.benzinga.com/analyst-ratings/price-target/25/05/45262278/under-armour-faces-tough-road-ahead-says-analyst"> </a> • <a href="https://www.benzinga.com/analyst-ratings/price-target/25/05/45262278/under-armour-faces-tough-road-ahead-says-analyst">Wall Street Reacts As Airbnb Eyes Growth Amid US Slowdown</a>
Photo: Boumen Japet via Shutterstock

Analyst Color

Reiteration

Travel

Analyst Ratings

Trading Ideas

ABNB

3 Airbnb Initiatives That Could Unleash Growth Opportunities

Precision BioSciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DTIL#NASDAQ">DTIL</a>) is set to give its latest quarterly earnings report on Thursday, 2025-05-15. Here's what investors need to know before the announcement.
Analysts estimate that Precision BioSciences will report an earnings per share (EPS) of $-2.42. 
Precision BioSciences bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Historical Earnings Performance</h3>
In the previous earnings release, the company beat EPS by $0.72, leading to a 0.22% increase in the share price the following trading session.

<img src="https://www.benzinga.com/files/images/story/2025/1747238745_0.png" alt="eps graph" />
<h3>Precision BioSciences Share Price Analysis</h3>
Shares of Precision BioSciences were trading at $5.145 as of May 13. Over the last 52-week period, shares are down 57.72%. Given that these returns are generally negative, long-term shareholders are likely a little upset going into this earnings release. 
<a href="https://www.benzinga.com/quote/DTIL/earnings">To track all earnings releases for Precision BioSciences visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings

DTIL

Uncovering Potential: Precision BioSciences's Earnings Preview

Piper Sandler analyst Edward Tenthoff maintains ITeos Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ITOS#NASDAQ">ITOS</a>) with a Overweight and lowers the price target from $16 to $12.

News

Price Target

ITOS

Piper Sandler Maintains Overweight on ITeos Therapeutics, Lowers Price Target to $12

Piper Sandler analyst Biren Amin maintains Allogene Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALLO#NASDAQ">ALLO</a>) with a Overweight and lowers the price target from $9 to $7.

ALLO

Piper Sandler Maintains Overweight on Allogene Therapeutics, Lowers Price Target to $7

U.S. stocks were higher, with the Nasdaq Composite gaining around 100 points on Wednesday.
Shares of Tower Semiconductor Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSEM#NASDAQ">TSEM</a>) rose sharply during Wednesday's session following <a href="https://in.benzinga.com/news/earnings/25/05/45408724/tower-semiconductor-stock-dips-despite-q1-revenue-growth-as-margins-squeeze">better-than-expected quarterly results.</a>
Tower Semiconductor reported a quarterly revenue growth of 9% year-on-year to $358.17 million, compared to the analyst consensus estimate of $358.15 million. The Israel-based contract chipmaker's adjusted EPS of 45 cents beat the analyst consensus estimate of 38 cents.
Tower Semiconductor shares jumped 6.7% to $42.76 on Wednesday.
Here are some other big stocks recording gains in today&#8217;s session.
<ul class="wp-block-list">
<li>Regencell Bioscience Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGC#NASDAQ">RGC</a>) shares jumped 28.1% to $400.00.</li>
<li>Nutex Health Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NUTX#NASDAQ">NUTX</a>) gained 28.1% to $161.34 after the company reported better-than-expected first-quarter financial results.</li>
<li>Everus Construction Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ECG#NYSE">ECG</a>) rose 23.7% to $63.62 after the company reported better-than-expected first-quarter financial results.</li>
<li>Rigetti Computing, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGTI#NASDAQ">RGTI</a>) jumped 20.1% to $11.85.</li>
<li>LuxExperience B.V. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LUXE#NASDAQ">LUXE</a>) gained 19.2% to $10.61 after the company reported third-quarter financial results and beat its adjusted EPS and revenue estimates.</li>
<li>Kornit Digital Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KRNT#NASDAQ">KRNT</a>) rose 19.1% to $22.92 after the company reported better-than-expected first-quarter adjusted EPS results.</li>
<li>Super Micro Computer, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMCI#NASDAQ">SMCI</a>) gained 18.2% to $45.97 after the company announced improvements to its DLC-2 direct liquid cooling solutions and a deal with Saudi Arabian data center company DataVolt.</li>
<li>NeuroPace, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NPCE#NASDAQ">NPCE</a>) gained 18% to $15.28 after the company reported better-than-expected quarterly financial results and raised its FY25 sales guidance.</li>
<li>Oklo Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OKLO#NYSE">OKLO</a>) rose 17% to $37.47 following first-quarter results.</li>
<li>Reddit, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RDDT#NYSE">RDDT</a>) gained 14.4% to $129.06.</li>
<li>Tencent Music Entertainment Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TME#NYSE">TME</a>) gained 14.1% to $16.75 following first-quarter results.</li>
<li>Rocket Lab USA, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RKLB#NASDAQ">RKLB</a>) gained 9.1% to $23.81.</li>
<li>Liberty Global Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LBTYA#NASDAQ">LBTYA</a>) rose 8.7% to $9.87.</li>
<li>PVH Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PVH#NYSE">PVH</a>) gained 8.5% to $87.36. Jefferies analyst Ashley Helgans upgraded PVH from Hold to Buy and raised the price target from $70 to $105.</li>
<li>Wingstop Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WING#NASDAQ">WING</a>) rose 7.1% to $306.51. Wells Fargo, B of A Securities and TD Securities raised their price targets on the stock.</li>
<li>SoundHound AI, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOUN#NASDAQ">SOUN</a>) gained 6.6% to $12.00.</li>
<li>Affirm Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AFRM#NASDAQ">AFRM</a>) rose 6.1% to $57.24 after the company was named the pay-over-time provider for Costco.com in the US.</li>
<li>Tesla, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) gained 4.1% to $347.60. Tesla is reportedly preparing to restart the shipping of components from China to the U.S. for the production of its Cybercab and Semi trucks. This move follows a recent truce over tariffs between the U.S. and China.</li>
</ul>
Now Read This: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/analyst-ratings/price-target/25/05/45403847/coinbase-to-rally-around-17-here-are-10-top-analyst-forecasts-for-wednesday">Coinbase To Rally Around 17%? Here Are 10 Top Analyst Forecasts For Wednesday</a> </li>
</ul>
Photo via Shutterstock

Intraday Update

Markets

Movers

AFRM

KRNT

LBTYA

LUXE

NPCE

NUTX

OKLO

RDDT

RGTI

RKLB

SMCI

SOUN

TSEM

TSLA

WING

Tower Semiconductor Posts Upbeat Earnings, Joins Nutex Health, Kornit Digital, Tencent Music Entertainment And Other Big Stocks Moving Higher On Wednesday

Piper Sandler analyst Charles Neivert maintains Westlake (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WLK#NYSE">WLK</a>) with a Neutral and lowers the price target from $105 to $100.

Piper Sandler Maintains Neutral on Westlake, Lowers Price Target to $100

Financial giants have made a conspicuous bearish move on Vistra. Our analysis of options history for Vistra (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VST#NYSE">VST</a>) revealed 30 unusual trades.
Delving into the details, we found 36% of traders were bullish, while 56% showed bearish tendencies. Out of all the trades we spotted, 8 were puts, with a value of $2,006,097, and 22 were calls, valued at $1,100,244.
<h3>Projected Price Targets</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $105.0 to $180.0 for Vistra over the last 3 months. 
<h3>Volume &amp; Open Interest Development</h3>
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Vistra's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Vistra's whale trades within a strike price range from $105.0 to $180.0 in the last 30 days. 
<h3>Vistra Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1747238577_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>VST</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>07/18/25</td>
<td>$12.3</td>
<td>$11.85</td>
<td>$12.3</td>
<td>$150.00</td>
<td>$615.0K</td>
<td>300</td>
<td>2.0K</td>
</tr>
<tr>
<td>VST</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>07/18/25</td>
<td>$11.8</td>
<td>$11.45</td>
<td>$11.8</td>
<td>$150.00</td>
<td>$608.9K</td>
<td>300</td>
<td>1.5K</td>
</tr>
<tr>
<td>VST</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>07/18/25</td>
<td>$11.5</td>
<td>$11.15</td>
<td>$11.5</td>
<td>$150.00</td>
<td>$575.0K</td>
<td>300</td>
<td>1.0K</td>
</tr>
<tr>
<td>VST</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/15/27</td>
<td>$44.8</td>
<td>$44.0</td>
<td>$44.0</td>
<td>$160.00</td>
<td>$132.0K</td>
<td>114</td>
<td>30</td>
</tr>
<tr>
<td>VST</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>12/19/25</td>
<td>$34.3</td>
<td>$33.45</td>
<td>$33.49</td>
<td>$145.00</td>
<td>$83.7K</td>
<td>1.8K</td>
<td>25</td>
</tr>
</tbody>
</table>

<h3>About Vistra</h3>
Vistra Energy is one of the largest power producers and retail energy providers in the US. Following the 2024 Energy Harbor acquisition, Vistra owns 41 gigawatts of nuclear, coal, natural gas, solar, and energy storage assets. Its retail electricity business serves 5 million customers in 20 states, including almost a third of all Texas electricity consumers. Vistra emerged from the Energy Future Holdings bankruptcy as a stand-alone entity in 2016. It acquired Dynegy in 2018.
Having examined the options trading patterns of Vistra, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
<h3>Where Is Vistra Standing Right Now?</h3>
<ul>
<li>Trading volume stands at 2,428,904, with VST's price up by 1.45%, positioned at $157.25.</li>
<li>RSI indicators show the stock to be may be overbought.</li>
<li>Earnings announcement expected in 85 days.</li>
</ul>
<h3>What The Experts Say On Vistra</h3>
In the last month, 1 experts released ratings on this stock with an average target price of $160.0.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; An analyst from UBS persists with their Buy rating on Vistra, maintaining a target price of $160. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Vistra options trades with real-time alerts from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.

Options

Vistra Options Trading: A Deep Dive into Market Sentiment

Financial giants have made a conspicuous bullish move on AppLovin. Our analysis of options history for AppLovin (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APP#NASDAQ">APP</a>) revealed 74 unusual trades.
Delving into the details, we found 32% of traders were bullish, while 28% showed bearish tendencies. Out of all the trades we spotted, 8 were puts, with a value of $405,127, and 66 were calls, valued at $15,221,592.
<h3>What's The Price Target?</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $220.0 and $530.0 for AppLovin, spanning the last three months.
<h3>Analyzing Volume &amp; Open Interest</h3>
In today's trading context, the average open interest for options of AppLovin stands at 666.1, with a total volume reaching 66,492.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in AppLovin, situated within the strike price corridor from $220.0 to $530.0, throughout the last 30 days.
<h3>AppLovin Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1747238572_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>APP</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/16/26</td>
<td>$87.1</td>
<td>$85.0</td>
<td>$86.05</td>
<td>$390.00</td>
<td>$567.9K</td>
<td>70</td>
<td>66</td>
</tr>
<tr>
<td>APP</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$24.0</td>
<td>$23.2</td>
<td>$23.99</td>
<td>$400.00</td>
<td>$374.4K</td>
<td>8.5K</td>
<td>4.8K</td>
</tr>
<tr>
<td>APP</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>07/18/25</td>
<td>$54.8</td>
<td>$53.0</td>
<td>$54.11</td>
<td>$350.00</td>
<td>$221.8K</td>
<td>3.1K</td>
<td>71</td>
</tr>
<tr>
<td>APP</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>11/21/25</td>
<td>$82.1</td>
<td>$81.5</td>
<td>$82.1</td>
<td>$380.00</td>
<td>$205.2K</td>
<td>89</td>
<td>26</td>
</tr>
<tr>
<td>APP</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>07/18/25</td>
<td>$40.3</td>
<td>$39.0</td>
<td>$39.48</td>
<td>$380.00</td>
<td>$161.8K</td>
<td>263</td>
<td>65</td>
</tr>
</tbody>
</table>

<h3>About AppLovin</h3>
AppLovin is a vertically integrated advertising technology company that acts as a demand-side platform for advertisers, a supply-side platform for publishers, and an exchange facilitating transactions between the two. About 80% of AppLovin's revenue comes from the DSP, AppDiscovery, while the remainder comes from the SSP, Max, and gaming studios, which develop mobile games. AppLovin announced in February 2025 its plans to divest from the lower-margin gaming studios to focus exclusively on the ad tech platform. AppLovin's primary tool for future growth is Axon 2, which is an ad optimizer operating within the DSP that allows advertisers to place ads according to specified return thresholds.
Having examined the options trading patterns of AppLovin, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
<h3>AppLovin's Current Market Status</h3>
<ul>
<li>Trading volume stands at 2,885,645, with APP's price up by 0.58%, positioned at $372.24.</li>
<li>RSI indicators show the stock to be may be overbought.</li>
<li>Earnings announcement expected in 84 days.</li>
</ul>
<h3>Expert Opinions on AppLovin</h3>
5 market experts have recently issued ratings for this stock, with a consensus target price of $448.0.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; An analyst from JP Morgan persists with their Neutral rating on AppLovin, maintaining a target price of $355. 
&#x2A; An analyst from Jefferies persists with their Buy rating on AppLovin, maintaining a target price of $530. 
&#x2A; An analyst from Morgan Stanley has decided to maintain their Overweight rating on AppLovin, which currently sits at a price target of $420. 
&#x2A; An analyst from Goldman Sachs persists with their Neutral rating on AppLovin, maintaining a target price of $435. 
&#x2A; An analyst from Oppenheimer downgraded its action to Outperform with a price target of $500. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest AppLovin options trades with real-time alerts from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.

Unpacking the Latest Options Trading Trends in AppLovin

President Doanld Trump led a high-profile delegation of U.S. tech CEOs, including Nvidia's Jensen Huang, to an investment conference in Saudi Arabia on Tuesday. Trump and Saudi Crown Prince Mohammed bin Salman jointly announced a $600 billion investment package, which included massive AI infrastructure<a href="https://www.benzinga.com/news/large-cap/25/05/45405067/saudi-arabia-bets-big-on-ai-teams-up-with-aws-and-nvidia"> partnerships with Nvidia Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>). </a>
The Details: As part of the visit, the Trump administration announced the rescinding of Biden-era restrictions on the export of advanced U.S. AI chips, clearing the way for Nvidia and other American firms to supply processors to Saudi Arabia and the UAE. 
Nvidia announced that <a href="https://www.benzinga.com/quote/NVDA#:~:text=Saudi%20Arabia%20Bets,expand%20global%20demand">it partnered </a>with several leading Saudi organizations to collaborate on AI initiatives.
It&#8217;s worth noting that the Biden administration implemented restrictions on the export of advanced semiconductor chips to Saudi Arabia, primarily due to concerns about potential risks to U.S. national security and the possibility of these chips being diverted to China
Read Next: <a href="https://www.benzinga.com/general/health-care/25/05/45384935/trump-again-promises-lower-drug-prices-by-cutting-out-middlemen-like-unitedhealth-cvs-will-it-work-this-time?utm_source=articleShare">Trump Again Promises Lower Drug Prices By &#8216;Cutting Out Middlemen&#8217; Like UnitedHealth, CVS: Will It Work This Time?</a>
HUMAIN, a subsidiary of Saudi Arabia's Public Investment Fund dedicated to artificial intelligence, will construct AI factories across Saudi Arabia powered by several hundred thousand of Nvidia's most advanced GPUs over the next five years with a projected total capacity of up to 500 megawatts.&nbsp;
The first stage of the rollout features the deployment of an 18,000-unit Nvidia GB300 Grace Blackwell AI supercomputer, integrated with Nvidia InfiniBand networking for high-speed connectivity.
In addition, HUMAIN will introduce Saudi Arabia's first Nvidia Omniverse Cloud platform, enabling the simulation and testing of physical AI solutions through digital twins.&nbsp;
&#8220;AI, like electricity and internet, is essential infrastructure for every nation,&#8221; Huang said. &#8220;Together with HUMAIN, we are building AI infrastructure for the people and companies of Saudi Arabia to realize the bold vision of the Kingdom.&#8221;
Additionally, Nvidia and the Saudi Data &amp; AI Authority (SDAIA) will deploy up to 5,000 Blackwell GPUs to establish a sovereign AI factory and advance smart city initiatives. The partnership will also provide training for government and university scientists and engineers to equip them with the skills needed to develop and implement models for both physical and agentic AI.&nbsp;
It was also announced that Aramco Digital will build AI computing infrastructure, partner with Nvidia's startup ecosystem, launch AI enterprise platforms, and establish a center of excellence for engineering and robotics incorporating Nvidia technologies.
Expert Ideas: Bank of America Securities analyst Vivek Arya estimated the size of the HUMAIN deals to be between $2 billion to $3 billion annually, likely starting in 2025, with a total of between $15 billion and $20 billion over a multi-year period. 
The analyst also pointed to Sovereign AI as a potential offset to China export restrictions and limited data center power capabilities in the U.S.
Bank of America maintained its Buy rating on Nvidia shares and raised its price target from $150 to $160 on the Saudi investments.
Read Next:&nbsp;
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/earnings/25/05/45353123/quantum-stocks-are-hot-in-2025-biggest-movers-to-watch?utm_source=articleShare">Quantum Stocks Are Hot In 2025: Biggest Movers To Watch&nbsp;</a></li>
</ul>
Photo: Shutterstock

Large Cap

Politics

Tech

NVDA

Nvidia Climbs On Saudi AI Investments: Analyst Estimates $15 Billion To $20 Billion In Revenue

Deep-pocketed investors have adopted a bearish approach towards Eli Lilly (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LLY#NYSE">LLY</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in LLY usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 69 extraordinary options activities for Eli Lilly. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 34% leaning bullish and 40% bearish. Among these notable options, 25 are puts, totaling $2,733,522, and 44 are calls, amounting to $3,125,976.
<h3>Expected Price Movements</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $300.0 and $1200.0 for Eli Lilly, spanning the last three months.
<h3>Volume &amp; Open Interest Development</h3>
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Eli Lilly's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Eli Lilly's whale trades within a strike price range from $300.0 to $1200.0 in the last 30 days. 
<h3>Eli Lilly Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1747238567_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>LLY</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$12.35</td>
<td>$11.8</td>
<td>$12.35</td>
<td>$800.00</td>
<td>$617.5K</td>
<td>3.2K</td>
<td>604</td>
</tr>
<tr>
<td>LLY</td>
<td>PUT</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>12/18/26</td>
<td>$381.7</td>
<td>$376.15</td>
<td>$378.92</td>
<td>$1100.00</td>
<td>$493.2K</td>
<td>0</td>
<td>186</td>
</tr>
<tr>
<td>LLY</td>
<td>PUT</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>12/18/26</td>
<td>$381.6</td>
<td>$376.25</td>
<td>$378.92</td>
<td>$1100.00</td>
<td>$379.0K</td>
<td>0</td>
<td>186</td>
</tr>
<tr>
<td>LLY</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>05/23/25</td>
<td>$3.45</td>
<td>$3.4</td>
<td>$3.4</td>
<td>$670.00</td>
<td>$262.5K</td>
<td>152</td>
<td>1.0K</td>
</tr>
<tr>
<td>LLY</td>
<td>PUT</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>07/18/25</td>
<td>$357.0</td>
<td>$351.0</td>
<td>$354.0</td>
<td>$1080.00</td>
<td>$212.4K</td>
<td>5</td>
<td>6</td>
</tr>
</tbody>
</table>

<h3>About Eli Lilly</h3>
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
Following our analysis of the options activities associated with Eli Lilly, we pivot to a closer look at the company's own performance.
<h3>Present Market Standing of Eli Lilly</h3>
<ul>
<li>With a trading volume of 2,442,567, the price of LLY is down by -2.66%, reaching $726.23.</li>
<li>Current RSI values indicate that the stock is is currently neutral between overbought and oversold.</li>
<li>Next earnings report is scheduled for 85 days from now.</li>
</ul>
<h3>Professional Analyst Ratings for Eli Lilly</h3>
In the last month, 3 experts released ratings on this stock with an average target price of $908.33.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; Reflecting concerns, an analyst from HSBC lowers its rating to Reduce with a new price target of $700. 
&#x2A; Consistent in their evaluation, an analyst from UBS keeps a Buy rating on Eli Lilly with a target price of $1050. 
&#x2A; An analyst from Cantor Fitzgerald has revised its rating downward to Overweight, adjusting the price target to $975. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Eli Lilly, <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> gives you real-time options trades alerts.

Unpacking the Latest Options Trading Trends in Eli Lilly

Piper Sandler analyst Kashy Harrison maintains Plug Power (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLUG#NASDAQ">PLUG</a>) with a Underweight and lowers the price target from $1.1 to $0.8.

PLUG

Piper Sandler Maintains Underweight on Plug Power, Lowers Price Target to $0.8

MongoDB's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MDB#NYSE">MDB</a>) short percent of float has fallen 25.42% since its last report. The company recently reported that it has 2.82 million shares sold short, which is 3.58% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.28 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>MongoDB Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1747238438_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for MongoDB has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing MongoDB's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, MongoDB's peer group average for short interest as a percentage of float is 7.01%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

Is the Market Bullish or Bearish on MongoDB?

CACI International's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CACI#NYSE">CACI</a>) short percent of float has fallen 14.34% since its last report. The company recently reported that it has 1.34 million shares sold short, which is 6.87% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.85 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>CACI International Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1747238432_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for CACI International has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing CACI International's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, CACI International's peer group average for short interest as a percentage of float is 4.74%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

CACI

How Do Investors Really Feel About CACI International?

In the current market session, Chemed Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CHE#NYSE">CHE</a>) price is at $571.49, after a 2.57% spike. However, over the past month, the stock fell by 4.54%, and in the past year, by 2.35%. Shareholders might be interested in knowing whether the stock is undervalued, even if the company is performing up to par in the current session. 

<img src="https://www.benzinga.com/files/images/story/2025/1747238428_0.png" alt="Past Year Chart" />

<h3>Chemed P/E Compared to Competitors</h3>
The P/E ratio is used by long-term shareholders to assess the company's market performance against aggregate market data, historical earnings, and the industry at large. A lower P/E could indicate that shareholders do not expect the stock to perform better in the future or it could mean that the company is undervalued. 
Compared to the aggregate P/E ratio of the 55.75 in the Health Care Providers &amp; Services industry, Chemed Inc. has a lower P/E ratio of 27.17. Shareholders might be inclined to think that the stock might perform worse than it's industry peers. It's also possible that the stock is undervalued. 

<img src="https://www.benzinga.com/files/images/story/2025/1747238428_1.png" alt="Guage" />

In conclusion, the price-to-earnings ratio is a useful metric for analyzing a company's market performance, but it has its limitations. While a lower P/E can indicate that a company is undervalued, it can also suggest that shareholders do not expect future growth. Additionally, the P/E ratio should not be used in isolation, as other factors such as industry trends and business cycles can also impact a company's stock price. Therefore, investors should use the P/E ratio in conjunction with other financial metrics and qualitative analysis to make informed investment decisions.

P/E Ratio Insights for Chemed

Workday's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WDAY#NYSE">WDAY</a>) short percent of float has fallen 11.25% since its last report. The company recently reported that it has 6.11 million shares sold short, which is 2.84% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.88 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Workday Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1747238427_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Workday has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Workday's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Workday's peer group average for short interest as a percentage of float is 3.03%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

WDAY

How Do Investors Really Feel About Workday?

Piper Sandler analyst Derek Podhaizer maintains Flowco Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FLOC#NYSE">FLOC</a>) with a Overweight and lowers the price target from $34 to $33.

FLOC

Piper Sandler Maintains Overweight on Flowco Holdings, Lowers Price Target to $33

The Magnificent Seven megacap stocks have tacked on an astonishing $3.57 trillion combined market value since April 8, powered by a sweeping reversal in global trade sentiment following the 90-day tariff pause and <a href="https://www.benzinga.com/topic/tariffs">U.S.-China trade truce.</a>
Notably, $1.2 trillion of that gain has occurred in just three days after the May 12 U.S.-China de-escalation. 
<h3 class="wp-block-heading">From Tariff Panic To Trillion-Dollar Gains</h3>
The rally began after the April 9 announcement of a 90-day pause on new tariffs—just one week after the U.S. introduced broad trade measures that had roiled global markets.
Optimism built steadily as Treasury Secretary Scott Bessent hinted at major trade progress with several partners. 
In May, two major diplomatic breakthroughs:
<ul class="wp-block-list">
<li>May 7: A U.S.-UK trade agreement slashed tariffs on autos and agriculture</li>
<li>May 12: A U.S.-China truce cut tariffs by 115 percentage points, replacing the expected April hikes with reduced rates of 30pp from the U.S. and 15pp from China—effective for 90 days. </li>
</ul>
&#8220;Recent positive news on U.S. trade policy, combined with easing financial conditions, has led our economists to raise their growth forecasts for the U.S., Europe, and China, and reduce the U.S. recession probability to 35% from 45%,&#8221; Goldman Sachs said in a note Wednesday.
<h3 class="wp-block-heading">Mag7 Market Cap Gains Since April 8</h3>
<figure class="wp-block-table is-style-stripes"> 
<table class="has-fixed-layout">
<thead>
<tr>
<th>Company</th>
<th>April 8 Market Cap</th>
<th>May 15 Market Cap</th>
<th>Market Cap Gain</th>
<th>% Rally</th>
</tr>
</thead>
<tbody>
<tr>
<td>Microsoft Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>)</td>
<td>$2,635.79B</td>
<td>$3,360.04B</td>
<td>+$724.25B</td>
<td>+27.5%</td>
</tr>
<tr>
<td>Nvidia Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>)</td>
<td>$2,349.72B</td>
<td>$3,229.57B</td>
<td>+$879.85B</td>
<td>+37.5%</td>
</tr>
<tr>
<td>Apple Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>)</td>
<td>$2,590.11B</td>
<td>$3,185.35B</td>
<td>+$595.24B</td>
<td>+23.6%</td>
</tr>
<tr>
<td>Amazon.com Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>)</td>
<td>$1,808.61B</td>
<td>$2,235.62B</td>
<td>+$427.01B</td>
<td>+23.5%</td>
</tr>
<tr>
<td>Alphabet Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>)</td>
<td>$1,774.23B</td>
<td>$1,965.05B</td>
<td>+$190.82B</td>
<td>+11.7%</td>
</tr>
<tr>
<td>Meta Platforms Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>)</td>
<td>$1,293.31B</td>
<td>$1,654.51B</td>
<td>+$361.20B</td>
<td>+28.5%</td>
</tr>
<tr>
<td>Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>)</td>
<td>$713.62B</td>
<td>$1,101.28B</td>
<td>+$387.66B</td>
<td>+54.1%</td>
</tr>
</tbody>
</table>
</figure>
<ul class="wp-block-list">
<li>Total Market Cap Gain: $3.57 trillion</li>
</ul>
<h3 class="wp-block-heading">Nasdaq 100 Posts Rare 25-Session Surge</h3>
The market shift hasn&#8217;t been confined to just mega-cap tech names. 
The Nasdaq 100 Index – as tracked by the Invesco QQQ Trust, Series 1 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>) – has now posted one of its strongest 25-session rallies in history, surging 24.5% since April 8.
That puts this advance on par with historic rebounds during major turning points:
<ul class="wp-block-list">
<li>April 2020: +26.4%</li>
<li>April 2009: +26.6%</li>
<li>November 2002: +25.8%</li>
<li>November 2001: +31.0%</li>
</ul>
Only a handful of periods in the last two decades have seen such rapid upward repricing, mostly during post-crisis recoveries.
&#8220;Those events all registered as market bottoms,&#8221; Goldman Sachs&#8217; analyst Peter Callahan said.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/25/05/45406180/only-half-of-sp-500-stocks-joined-the-tariff-relief-rally-time-to-buy-the-laggards">Only Half Of S&amp;P 500 Stocks Joined The Tariff-Relief Rally: Time To Buy The Laggards? </a></li>
</ul>
Photo: Shutterstock

Equities

Government

Regulations

Broad U.S. Equity ETFs

Economics

ETFs

AAPL

AMZN

GOOGL

MSFT

Magnificent Seven Add $3.6 Trillion Since April Lows: Is This Rally Just Beginning?

TotalEnergies SE (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TTE#NYSE">TTE</a>) shares are trading lower on Wednesday after the company disclosed that it has agreed with HitecVision, a Norwegian energy investment firm, to sell a 50% stake in Polska Grupa Biogazowa (PGB) for <a href="https://totalenergies.com/news/press-releases/biogas-totalenergies-and-hitecvision-partner-pursue-development-polska-grupa" target="_blank" rel="noreferrer noopener">an</a> enterprise value of 190 million euros ($213 million).
PGB is the leading biogas producer in Poland, with 20 operational units and a production capacity exceeding 450 GWh of equivalent biomethane.
Notably, PGB was acquired by TotalEnergies in 2023 and operates biogas plants that produce electricity and heat through combined heat and power (CHP).
Also Read: <a target="_blank" href="https://www.benzinga.com/news/large-cap/25/04/44902787/chevron-totalenergies-fire-up-ballymore-deepwater-gulf-project-targeting-150-million-barrels-over-life" rel="noreferrer noopener">Chevron &amp; TotalEnergies Fire Up Ballymore: Deepwater Gulf Project Targeting 150 Million Barrels Over Life</a>
PGB currently has two plants under construction in Poland and plans to expand into biomethane production, aiming for a total equivalent biomethane production capacity of 2 TWh by 2030.
Stéphane Michel, President of Gas, Renewables &amp; Power at TotalEnergies, said, &#8220;This transaction will enable PGB to continue its growth in a country where biogas is rapidly developing and is in line with the farmdown business model applied to our renewable assets in order to maximize the profitability of our investments.&#8221;&nbsp;
Erlend Ellingsen, CEO and Managing Partner of HitecVision, added, &#8220;Biogas and biomethane is a core focus for HitecVision&#8217;s New Energy Program, and Poland represents a unique market opportunity to pursue profitable growth while contributing to the decarbonization of Poland and the EU.&#8221;
&#8220;TotalEnergies has a well-established industrial footprint in Poland, and we as partners have complementary skillsets that we jointly will put to use for scaling PGB significantly over the next few years through greenfield projects as well as M&amp;A.&#8221;
In April, the company&nbsp;reported&nbsp;first-quarter adjusted EPS of&nbsp;$1.83, down 15% year over year (Y/Y),&nbsp;and&nbsp;missed the consensus of&nbsp;$1.88, and sales&nbsp;of&nbsp;$52.25 billion&nbsp;topped <a target="_blank" href="https://www.benzinga.com/news/earnings/25/04/45113720/totalenergies-misses-q1-earnings-but-lifts-dividend-plans-2-billion-buyback" rel="noreferrer noopener">the consensus of&nbsp;$44.91 billion</a>.
Investors can gain exposure to the stock via FT Energy Income Partners Strategy ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EIPX#NYSE">EIPX</a>) and&nbsp;First Trust Exchange-Traded Fund VIII FT Energy Income Partners Enhanced Income ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EIPI#NYSE">EIPI</a>).
Price Action: TTE shares are down 0.92% to $59.35 at the last check on Wednesday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/25/04/44816075/totalenergies-inks-20-year-lng-deal-with-nextdecade-awaits-key-investment-decision" target="_blank" rel="noreferrer noopener">TotalEnergies Inks 20-Year LNG Deal With NextDecade, Awaits Key Investment Decision</a></li>
</ul>
Image by sdf_qwe via Shutterstock

Asset Sales

EIPI

First Trust Exchange-Traded Fund IV FT Energy Income Partners Strategy ETF

EIPX

Why Is TotalEnergies Stock Trading Lower On Wednesday?

Piper Sandler analyst James Fish maintains Samsara (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IOT#NYSE">IOT</a>) with a Overweight and raises the price target from $44 to $53.

Piper Sandler Maintains Overweight on Samsara, Raises Price Target to $53

Rumors

IPOs

ETOR

Etoro Group IPO Price Indicating $67.60 On 1M Shares; IPO Priced At $52/Share On 11,923,018 Shares

Press Releases

"Peraso Inc. (NASDAQ: PRSO) Revolutionizes Consumer Experiences with Game-Changing mmWave Technology" more stocks inside….

Health Care

Rani Therapeutics Announces New Preclinical Pharmacokinetic Data Supporting Transenteric Delivery of GLP-1 Incretin Triagonist

Peraso Inc. (NASDAQ: PRSO): Revolutionizing Military Combat with Steerable Beam Technology see more stocks inside…

Rani Therapeutics to Participate in Upcoming Investor Conferences

Rani Therapeutics Reports Third Quarter 2024 Financial Results; Provides Corporate Update

General

Rani Therapeutics Announces Preclinical Data Demonstrating Successful Oral Delivery of Semaglutide via RaniPill® HC

Rani Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results

Rani Therapeutics Announces Preclinical Data Demonstrating Bioequivalence of RT-114, a GLP-1/GLP-2 Dual Agonist (PG-102) Delivered Orally via the RaniPill® Capsule, to Subcutaneously Administered PG-102

Rani Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results; Provides Corporate Update

Rani Therapeutics Reports First Quarter 2025 Financial Results; Provides Corporate Update

BNZI

BREA

DRUG

ILLR

NIVF

NIXX

PRSO

RANI

STAF

TVGN

VMAR

VSME

XPON

Addex Therapeutics Ltd - American Depositary Shares

Addex Therapeutics

Aspire Biopharma Holdings, Inc. - Common Stock

Aspire Biopharma Hldgs

Athira Pharma

Aytu BioPharma

CalciMedica

Cognition Therapeutics, Inc. - Common Stock

Cognition Therapeutics

Cingulate

Cocrystal Pharma

Dare Bioscience

Durect

Gelteq

Hoth Therapeutics

IGC Pharma

Jupiter Neurosciences, Inc. - Common Stock

Jupiter Neurosciences

Kiora Pharmaceuticals, Inc. - Common Stock

Kiora Pharmaceuticals

Lexaria Bioscience

Lipocine

MIRA Pharmaceuticals, Inc. - Common Stock

Mira Pharmaceuticals

ProPhase Labs

Pulmatrix

Relmada Therapeutics, Inc. - Common Stock

Relmada Therapeutics

Scilex Holding

Talphera

TherapeuticsMD

VYNE Therapeutics

HC Wainwright & Co.

Canaccord Genuity

Oppenheimer

Maxim Group

WIIM

Rani Therapeutics Holdings shares are trading higher. The company reported Q1 financial results.

Comments

Rani Therapeutics Hldgs

空売り

Rani Therapeutics Hldgs (NASDAQ:RANI) 株価情報, 空売り情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル